{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:12:32Z","timestamp":1785798752952,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08151-6","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:35:16Z","timestamp":1778506516000},"page":"4369-4382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The presence of anti-Ro52\/SSA antibodies may predict concomitant pulmonary hypertension and poorer survival in patients with connective tissue disease-associated interstitial lung disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Shih-Hsin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chiang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ku","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Jieh","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung-Liang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-1423","authenticated-orcid":false,"given":"Der-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"8151_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964","journal-title":"Ann Rheum Dis"},{"key":"8151_CR2","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755","journal-title":"Ann Rheum Dis"},{"key":"8151_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) Rheumatoid arthritis classification criteria: an ACR\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"8151_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"8151_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar3097","volume":"12","author":"FV Castelino","year":"2010","unstructured":"Castelino FV, Varga J (2010) Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 12:213","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"8151_CR6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/jcm9061606","volume":"9","author":"B Atienza-Mateo","year":"2020","unstructured":"Atienza-Mateo B, Remuzgo-Mart\u00ednez S, Cuesta VMM, Iturbe-Fern\u00e1ndez D, Fern\u00e1ndez-Rozas S, Prieto-Pe\u00f1a D et al (2020) The spectrum of interstitial lung disease associated with autoimmune diseases: data of a 3.6-year prospective study from a referral center of interstitial lung disease and lung transplantation. J Clin Med 9(6):1606","journal-title":"J Clin Med"},{"key":"8151_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.semarthrit.2020.07.011","volume":"50","author":"KH Ng","year":"2020","unstructured":"Ng KH, Chen DY, Lin CH, Chao WC, Chen YM, Chen YH et al (2020) Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: a nationwide, population-based cohort study. Semin Arthritis Rheum 50:840\u2013845","journal-title":"Semin Arthritis Rheum"},{"key":"8151_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/1535370218824101","volume":"244","author":"E Zanatta","year":"2019","unstructured":"Zanatta E, Polito P, Famoso G, Larosa M, De Zorzi E, Scarpieri E et al (2019) Pulmonary arterial hypertension in connective tissue disorders: pathophysiology and treatment. Exp Biol Med (Maywood) 244:120\u2013131. https:\/\/doi.org\/10.1177\/1535370218824101","journal-title":"Exp Biol Med (Maywood)"},{"key":"8151_CR9","doi-asserted-by":"crossref","unstructured":"Lef\u00e8vre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M et al (2013) Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum 65:2412\u20132423","DOI":"10.1002\/art.38029"},{"issue":"1494\u20131504","key":"8151_CR10","first-page":"840","volume":"146","author":"L Chung","year":"2014","unstructured":"Chung L, Farber HW, Benza R, Miller DP, Parsons L, Hassoun PM et al (2014) Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest 146(1494\u20131504):840\u2013845","journal-title":"Chest"},{"key":"8151_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12276","volume":"13","author":"V Khangoora","year":"2023","unstructured":"Khangoora V, Bernstein EJ, King CS, Shlobin OA (2023) Connective tissue disease-associated pulmonary hypertension: a comprehensive review. Pulm Circ 13:e12276","journal-title":"Pulm Circ"},{"issue":"4","key":"8151_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103506","volume":"23","author":"B Thoreau","year":"2024","unstructured":"Thoreau B, Mouthon L (2024) Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): recent and advanced data. Autoimmun Rev 23(4):103506","journal-title":"Autoimmun Rev"},{"issue":"SI","key":"8151_CR13","doi-asserted-by":"publisher","first-page":"SI140","DOI":"10.1093\/rheumatology\/keae166","volume":"64","author":"K Morrisroe","year":"2025","unstructured":"Morrisroe K, Hansen D, Stevens W, Ross L, Sahhar J, Ngian GS, Hill C, Host L, Walker J, Proudman S, Nikpour M (2025) Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis. Rheumatology (Oxford) 64(SI):SI140\u2013SI148. https:\/\/doi.org\/10.1093\/rheumatology\/keae166","journal-title":"Rheumatology (Oxford)"},{"key":"8151_CR14","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s10067-023-06667-9","volume":"42","author":"J Huang","year":"2023","unstructured":"Huang J, An Q, Shi H, Li C, Zhang W, Wang L (2023) Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients\u2019 prognosis. Clin Rheumatol 42:3131\u20133142","journal-title":"Clin Rheumatol"},{"key":"8151_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","volume":"179","author":"HJ Kong","year":"2007","unstructured":"Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P et al (2007) Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 179:26\u201330","journal-title":"J Immunol"},{"key":"8151_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/03009742.2021.1887927","volume":"50","author":"A Lee","year":"2021","unstructured":"Lee A, Patterson KA, Tan DJ, Wilson ME, Proudman SM, Stevens W et al (2021) Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. Scand J Rheumatol 50:469\u2013474","journal-title":"Scand J Rheumatol"},{"key":"8151_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103536","volume":"23","author":"ME Martel","year":"2024","unstructured":"Martel ME, Leurs A, Launay D, Behal H, Chepy A, Collet A (2024) Prevalence of anti-Ro52-kDa\/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: data from a French cohort, a systemic review and meta-analysis. Autoimmun Rev 23:103536","journal-title":"Autoimmun Rev"},{"key":"8151_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.24267","volume":"60","author":"SC Mathai","year":"2009","unstructured":"Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM et al (2009) Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 60:569\u2013577","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8151_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1155\/2010\/686098","volume":"17","author":"S Mittoo","year":"2010","unstructured":"Mittoo S, Jacob T, Craig A, Bshouty Z (2010) Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease. Can Respir J 17(6):282\u2013286. https:\/\/doi.org\/10.1155\/2010\/686098","journal-title":"Can Respir J"},{"key":"8151_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"8151_CR21","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M et al (2023) 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61:2200879","journal-title":"Eur Respir J"},{"key":"8151_CR22","doi-asserted-by":"publisher","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","volume":"64","author":"G Kovacs","year":"2024","unstructured":"Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D et al (2024) Definition, classification, and diagnosis of pulmonary hypertension. Eur Respir J 64:2401324","journal-title":"Eur Respir J"},{"key":"8151_CR23","first-page":"213","volume":"39","author":"WC Huang","year":"2023","unstructured":"Huang WC, Hsieh SC, Wu YW, Hsieh TY, Wu YJ, Li KJ et al (2023) 2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Acta Cardiol Sin 39:213\u2013241","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"8151_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier AA, MacMahon H, Colby T, Gevenois PA, Goo JM, Leung ANC et al (2024) Fleischner Society: glossary of terms for thoracic imaging. Radiology 310(2):e232558","journal-title":"Radiology"},{"issue":"5","key":"8151_CR25","first-page":"1107","volume":"69","author":"TJ Barreiro","year":"2004","unstructured":"Barreiro TJ, Perillo I (2004) An approach to interpreting spirometry. Am Fam Physician 69(5):1107\u20131114","journal-title":"Am Fam Physician"},{"key":"8151_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","volume":"14","author":"EMT Lau","year":"2017","unstructured":"Lau EMT, Giannoulatou E, Celermajer DS, Humbert M (2017) Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol 14:603\u2013614","journal-title":"Nat Rev Cardiol"},{"key":"8151_CR27","doi-asserted-by":"publisher","first-page":"1759720X2110375","DOI":"10.1177\/1759720X211037519","volume":"13","author":"P Panagopoulos","year":"2021","unstructured":"Panagopoulos P, Goules A, Hoffmann-Vold AM, Matteson EL, Tzioufas A (2021) Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis 13:1759720X211037519. https:\/\/doi.org\/10.1177\/1759720X211037519","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"8151_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.iac.2023.01.005","volume":"43","author":"SM Matson","year":"2023","unstructured":"Matson SM, Demoruelle MK (2023 May) Connective tissue disease associated interstitial lung disease. Immunol Allergy Clin North Am 43(2):229\u2013244. https:\/\/doi.org\/10.1016\/j.iac.2023.01.005","journal-title":"Immunol Allergy Clin North Am"},{"key":"8151_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","volume":"86","author":"D Launary","year":"2007","unstructured":"Launary D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M (2007) Pulmonary arterial hypertension: a rare complication of primary Sj\u00f6gren\u2019s syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86:299\u2013315","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"8151_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.semarthrit.2020.06.005","volume":"50","author":"CY Lin","year":"2020","unstructured":"Lin CY, Ko CH, Hsu CY, Chen HA (2020) Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: a national cohort study in Taiwan. Semin Arthritis Rheum 50(5):957\u2013962","journal-title":"Semin Arthritis Rheum"},{"key":"8151_CR31","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.3390\/ijms241511995","volume":"24","author":"CC Tseng","year":"2023","unstructured":"Tseng CC, Sung YW, Chen KY, Wang PY, Yen CY et al (2023) The role of macrophages in connective tissue disease-associated interstitial lung disease: focusing on molecular mechanisms and potential treatment strategies. Int J Mol Sci 24:11995","journal-title":"Int J Mol Sci"},{"key":"8151_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3899\/jrheum.170307","volume":"45","author":"A Fischer","year":"2018","unstructured":"Fischer A, Kong AM, Swigris JJ, Cole AL, Raimundo K (2018) All-cause healthcare costs and mortality in patients with systemic sclerosis with lung involvement. J Rheumatol 45:235\u2013241","journal-title":"J Rheumatol"},{"key":"8151_CR33","doi-asserted-by":"publisher","first-page":"00309","DOI":"10.1183\/23120541.00309-2019","volume":"6","author":"P Ratanawatkul","year":"2020","unstructured":"Ratanawatkul P, Solomon JJ, Kim D, George MP, McGibbon LRM, Demoruelle MK et al (2020) Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA. ERJ Open Res 6:00309\u201302019","journal-title":"ERJ Open Res"},{"key":"8151_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.semarthrit.2019.11.005","volume":"50","author":"M Noviani","year":"2020","unstructured":"Noviani M, Saffari SE, Tan JL, Yip JWL, Teng GG, Law WG et al (2020) Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort. Semin Arthritis Rheum 50:473\u2013479","journal-title":"Semin Arthritis Rheum"},{"key":"8151_CR35","first-page":"9195157","volume":"1","author":"HT Yang","year":"2023","unstructured":"Yang HT, Hong XP, Guo JW, Zhong XL, Liao R, Liu CL, Liu LX, Li K, Chen YL, Liu DZ (2023) Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases. J Immunol Res 1:9195157","journal-title":"J Immunol Res"},{"key":"8151_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11739-016-1573-9","volume":"12","author":"L Donato","year":"2017","unstructured":"Donato L, Elisiana CG, Giuseppe G, Pietro S, Michele C, Brunetti ND et al (2017) Utility of FVC\/DLco ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension. Intern Emerg Med 12:319\u2013326","journal-title":"Intern Emerg Med"},{"key":"8151_CR37","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Gr\u00fcnig E, Bonderman D, Distler O, Khanna D et al (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73:1340\u20131349","journal-title":"Ann Rheum Dis"},{"key":"8151_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-023-03141-4","volume":"25","author":"V Hamberg","year":"2023","unstructured":"Hamberg V, Sohrabian A, Volkmann ER, Wildt M, Lofdahl A, Wuttge DM et al (2023) Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis\u2014an exploratory study. Arthritis Res Ther 25:162","journal-title":"Arthritis Res Ther"},{"key":"8151_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12213","volume":"13","author":"L Piccari","year":"2023","unstructured":"Piccari L et al (2023) Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute\u2019s Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulm Circ 13:e12213","journal-title":"Pulm Circ"},{"key":"8151_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106238","volume":"180","author":"RR Wang","year":"2022","unstructured":"Wang RR, Yuan TY, Wang JM, Chen YC, Zhao JL, Li MT et al (2022) Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective. Pharmacol Res 180:106238","journal-title":"Pharmacol Res"},{"key":"8151_CR41","first-page":"145","volume":"2","author":"PD Burbelo","year":"2010","unstructured":"Burbelo PD, Ching KH, Han BL, Bush ER, Reeves WH, Iadarola MJ (2010) Extraordinary antigenicity of the human Ro52 autoantigen. Am J Transl Res 2:145\u2013155","journal-title":"Am J Transl Res"},{"key":"8151_CR42","doi-asserted-by":"publisher","first-page":"36478","DOI":"10.1074\/jbc.M111.241786","volume":"286","author":"A Espinosa","year":"2011","unstructured":"Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Abelius MS, Sheng Y et al (2011) Anti-Ro52 autoantibodies from patients with Sj\u00f6gren\u2019s syndrome inhibit the Ro52 E3 ligase activity by blocking the E3\/E2 interface. J Biol Chem 286:36478\u201336491","journal-title":"J Biol Chem"},{"key":"8151_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2021.04.020","volume":"91","author":"P Decker","year":"2021","unstructured":"Decker P, Moulinet T, Lopez B, Dubucquoi S, Bonnotte B, Lakomy D et al (2021) Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases. Eur J Intern Med 91:45\u201352","journal-title":"Eur J Intern Med"},{"issue":"9","key":"8151_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.924899","volume":"11","author":"D Giuggioli","year":"2022","unstructured":"Giuggioli D, Riccieri V, Cipolletta E, Del Papa N, Ingegnoli F, Spinella A, Pellegrino G, Risa AM, de Pinto M, Papa S, Armentaro G et al (2022) Peripheral microangiopathy changes in pulmonary arterial hypertension related to systemic sclerosis: data from a multicenter observational study. Front Cardiovasc Med 11(9):924899","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl. 91","key":"8151_CR45","first-page":"S131","volume":"33","author":"M Wodkowski","year":"2015","unstructured":"Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M et al (2015) Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clin Exp Rheumatol 33(Suppl. 91):S131\u2013S135","journal-title":"Clin Exp Rheumatol"},{"key":"8151_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.semarthrit.2015.06.011","volume":"45","author":"M Hinchcliff","year":"2015","unstructured":"Hinchcliff M, Khanna S, Hsu VM, Lee J, Almagor O, Chang RW et al (2015) Survival in systemic sclerosis\u2013pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Semin Arthritis Rheum 45:309\u2013314","journal-title":"Semin Arthritis Rheum"},{"key":"8151_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.semarthrit.2021.03.011","volume":"51","author":"Z Brown","year":"2021","unstructured":"Brown Z, Proudman S, Morrisroe K, Stevens W, Hansen D, Nikpour M (2021) Screening for the early detection of pulmonary artery hypertension in patients with systemic sclerosis: a systemic review and meta-analysis of long-term outcomes. Semin Arthritis Rheum 51:495\u2013512","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08151-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:04:29Z","timestamp":1783400669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08151-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8151"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08151-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}